Company intelligence / Profile preview

Anitox

Lawrenceville, Georgia, United Statesanitox.com ↗

Ownership: Private
Development stage: Other

Overview

Anitox develops, manufactures, and commercializes patented antimicrobial preservatives, sanitizers, and additives for animal feeds. Their products are widely used to reduce bacterial loads (including Salmonella), improve gut health, enhance nutrient absorption, optimize fermentation processes for food/fuel/pharma applications, and support biosecurity by reducing viral contamination risk. The company operates globally with a strong scientific foundation since 1977.

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Small molecule (feed additives, antimicrobials)Biologic (fermentation process aids)
Industry: Agriculture & AgTech

Partnerships

Major fuel ethanol producers; global food/feed manufacturers; Iluma Alliance network partners

Beyond the preview

Go deeper on Anitox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anitox.

Explore the full profile